Division of Bioinformatics, Z-Tech Corporation, ICF International Company at NCTR/FDA, Jefferson, AR 72079, USA.
BMC Bioinformatics. 2010 Oct 7;11 Suppl 6(Suppl 6):S5. doi: 10.1186/1471-2105-11-S6-S5.
Endocrine disruptors (EDs) and their broad range of potential adverse effects in humans and other animals have been a concern for nearly two decades. Many putative EDs are widely used in commercial products regulated by the Food and Drug Administration (FDA) such as food packaging materials, ingredients of cosmetics, medical and dental devices, and drugs. The Endocrine Disruptor Knowledge Base (EDKB) project was initiated in the mid 1990's by the FDA as a resource for the study of EDs. The EDKB database, a component of the project, contains data across multiple assay types for chemicals across a broad structural diversity. This paper demonstrates the utility of EDKB database, an integral part of the EDKB project, for understanding and prioritizing EDs for testing.
The EDKB database currently contains 3,257 records of over 1,800 EDs from different assays including estrogen receptor binding, androgen receptor binding, uterotropic activity, cell proliferation, and reporter gene assays. Information for each compound such as chemical structure, assay type, potency, etc. is organized to enable efficient searching. A user-friendly interface provides rapid navigation, Boolean searches on EDs, and both spreadsheet and graphical displays for viewing results. The search engine implemented in the EDKB database enables searching by one or more of the following fields: chemical structure (including exact search and similarity search), name, molecular formula, CAS registration number, experiment source, molecular weight, etc. The data can be cross-linked to other publicly available and related databases including TOXNET, Cactus, ChemIDplus, ChemACX, Chem Finder, and NCI DTP.
The EDKB database enables scientists and regulatory reviewers to quickly access ED data from multiple assays for specific or similar compounds. The data have been used to categorize chemicals according to potential risks for endocrine activity, thus providing a basis for prioritizing chemicals for more definitive but expensive testing. The EDKB database is publicly available and can be found online at http://edkb.fda.gov/webstart/edkb/index.html.
内分泌干扰物(EDs)及其在人类和其他动物中广泛存在的潜在不良影响已引起关注近二十年。许多假定的 EDs 广泛用于食品和药物管理局(FDA)监管的商业产品,如食品包装材料、化妆品成分、医疗和牙科设备以及药物。内分泌干扰物知识库(EDKB)项目于 20 世纪 90 年代中期由 FDA 发起,作为 EDs 研究的资源。EDKB 数据库是该项目的一个组成部分,包含了广泛结构多样性的化学品的多种检测类型的跨库数据。本文展示了 EDKB 数据库(EDKB 项目的一个组成部分)在理解和优先考虑 EDs 进行测试方面的用途。
EDKB 数据库目前包含来自不同检测的 1800 多种 ED 的 3257 条记录,包括雌激素受体结合、雄激素受体结合、子宫育活性、细胞增殖和报告基因检测。每个化合物的信息,如化学结构、检测类型、效力等,都进行了组织,以便进行有效的搜索。用户友好的界面提供了快速导航、ED 布尔搜索以及用于查看结果的电子表格和图形显示。EDKB 数据库中实现的搜索引擎允许按以下一个或多个字段搜索:化学结构(包括精确搜索和相似性搜索)、名称、分子式、CAS 注册号、实验来源、分子量等。数据可以链接到其他公开可用的相关数据库,包括 TOXNET、Cactus、ChemIDplus、ChemACX、Chem Finder 和 NCI DTP。
EDKB 数据库使科学家和监管审查员能够快速访问特定或类似化合物的多种检测的 ED 数据。这些数据已用于根据内分泌活性的潜在风险对化学品进行分类,从而为优先考虑具有更高确定性但更昂贵的测试的化学品提供了依据。EDKB 数据库是公开的,可在 http://edkb.fda.gov/webstart/edkb/index.html 在线找到。